BHC
Price
$8.56
Change
-$0.20 (-2.28%)
Updated
Nov 15, 03:14 PM (EDT)
96 days until earnings call
CRON
Price
$2.04
Change
-$0.03 (-1.45%)
Updated
Nov 15, 03:11 PM (EDT)
109 days until earnings call
Ad is loading...

BHC vs CRON

Header iconBHC vs CRON Comparison
Open Charts BHC vs CRONBanner chart's image
Bausch Health Companies
Price$8.56
Change-$0.20 (-2.28%)
Volume$400
CapitalizationN/A
Cronos Group
Price$2.04
Change-$0.03 (-1.45%)
Volume$2.61K
CapitalizationN/A
BHC vs CRON Comparison Chart
Loading...
BHC
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
CRON
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
BHC vs. CRON commentary
Nov 15, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BHC is a Sell and CRON is a Hold.

COMPARISON
Comparison
Nov 15, 2024
Stock price -- (BHC: $8.76 vs. CRON: $2.07)
Brand notoriety: BHC: Notable vs. CRON: Not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: BHC: 40% vs. CRON: 96%
Market capitalization -- BHC: $3.86B vs. CRON: $1B
BHC [@Pharmaceuticals: Other] is valued at $3.86B. CRON’s [@Pharmaceuticals: Other] market capitalization is $1B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BHC’s FA Score shows that 1 FA rating(s) are green whileCRON’s FA Score has 1 green FA rating(s).

  • BHC’s FA Score: 1 green, 4 red.
  • CRON’s FA Score: 1 green, 4 red.
According to our system of comparison, BHC is a better buy in the long-term than CRON.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BHC’s TA Score shows that 3 TA indicator(s) are bullish while CRON’s TA Score has 2 bullish TA indicator(s).

  • BHC’s TA Score: 3 bullish, 5 bearish.
  • CRON’s TA Score: 2 bullish, 6 bearish.
According to our system of comparison, BHC is a better buy in the short-term than CRON.

Price Growth

BHC (@Pharmaceuticals: Other) experienced а -7.01% price change this week, while CRON (@Pharmaceuticals: Other) price change was +0.49% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -4.99%. For the same industry, the average monthly price growth was -7.80%, and the average quarterly price growth was -7.77%.

Reported Earning Dates

BHC is expected to report earnings on Feb 19, 2025.

CRON is expected to report earnings on Mar 04, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-4.99% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BHC($3.86B) has a higher market cap than CRON($1.01B). BHC YTD gains are higher at: 9.227 vs. CRON (-0.957). BHC has higher annual earnings (EBITDA): 2.2B vs. CRON (-71.8M). BHC has more cash in the bank: 947M vs. CRON (862M). CRON has less debt than BHC: CRON (2.55M) vs BHC (22.4B). BHC has higher revenues than CRON: BHC (8.76B) vs CRON (87.2M).
BHCCRONBHC / CRON
Capitalization3.86B1.01B384%
EBITDA2.2B-71.8M-3,067%
Gain YTD9.227-0.957-964%
P/E Ratio13.39N/A-
Revenue8.76B87.2M10,042%
Total Cash947M862M110%
Total Debt22.4B2.55M877,399%
FUNDAMENTALS RATINGS
BHC vs CRON: Fundamental Ratings
BHC
CRON
OUTLOOK RATING
1..100
7968
VALUATION
overvalued / fair valued / undervalued
1..100
29
Undervalued
66
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10092
PRICE GROWTH RATING
1..100
3961
P/E GROWTH RATING
1..100
991
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BHC's Valuation (29) in the Pharmaceuticals Other industry is somewhat better than the same rating for CRON (66). This means that BHC’s stock grew somewhat faster than CRON’s over the last 12 months.

BHC's Profit vs Risk Rating (100) in the Pharmaceuticals Other industry is in the same range as CRON (100). This means that BHC’s stock grew similarly to CRON’s over the last 12 months.

CRON's SMR Rating (92) in the Pharmaceuticals Other industry is in the same range as BHC (100). This means that CRON’s stock grew similarly to BHC’s over the last 12 months.

BHC's Price Growth Rating (39) in the Pharmaceuticals Other industry is in the same range as CRON (61). This means that BHC’s stock grew similarly to CRON’s over the last 12 months.

CRON's P/E Growth Rating (1) in the Pharmaceuticals Other industry is significantly better than the same rating for BHC (99). This means that CRON’s stock grew significantly faster than BHC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BHCCRON
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
79%
Momentum
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
72%
Bearish Trend 2 days ago
87%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
79%
Bullish Trend 2 days ago
77%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
70%
Bearish Trend 2 days ago
83%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
72%
Bullish Trend 2 days ago
81%
Aroon
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
89%
View a ticker or compare two or three
Ad is loading...
BHC
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
CRON
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME27.370.91
+3.44%
GameStop Corp
AAPL228.223.10
+1.38%
Apple
SPY593.35-3.84
-0.64%
SPDR® S&P 500® ETF Trust
BTC.X87250.430000-3333.734400
-3.68%
Bitcoin cryptocurrency
TSLA311.18-19.06
-5.77%
Tesla

BHC and

Correlation & Price change

A.I.dvisor tells us that BHC and PRFX have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BHC and PRFX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BHC
1D Price
Change %
BHC100%
-0.23%
PRFX - BHC
27%
Poorly correlated
-10.81%
PAHC - BHC
26%
Poorly correlated
-1.46%
CRON - BHC
26%
Poorly correlated
-4.61%
HLN - BHC
26%
Poorly correlated
+0.87%
SWDCF - BHC
25%
Poorly correlated
N/A
More

CRON and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRON has been closely correlated with TLRY. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if CRON jumps, then TLRY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRON
1D Price
Change %
CRON100%
-4.61%
TLRY - CRON
72%
Closely correlated
-4.17%
ACB - CRON
69%
Closely correlated
-4.41%
CGC - CRON
69%
Closely correlated
-5.08%
OGI - CRON
64%
Loosely correlated
-5.06%
FLGC - CRON
35%
Loosely correlated
+15.93%
More